News | December 19, 2012

More Children Surviving In-Hospital Cardiac Arrest

Three times as many children survived in-hospital cardiac arrest in 2009 vs. 2000, according to a new study

December 19, 2012 — Hospitalized children who suffer cardiac arrest are nearly three times more likely to survive than they were about a decade ago, and no more likely to suffer brain impairment, according to new research in the American Heart Association journal Circulation: Cardiovascular Quality and Outcomes.

Researchers analyzed the cases of 1,031 children who suffered cardiac arrest at 12 urban U.S. teaching hospitals from 2000-2009. The hospitals participate in the American Heart Association's Get With the Guidelines-Resuscitation program, a quality-improvement effort that promotes consistent application of the latest scientific guidance for resuscitation.

In 2009, 43.4 percent of children studied survived until they were released from the hospital compared to 14.3 percent in 2000. Among surviving children, the risk of brain impairment has remained unchanged during this period.

"Survival in children who experience a cardiac arrest in the hospital has increased nearly threefold during the past decade, and most of those who survive are without severe neurological disability," said Saket Girotra, M.D., lead author of the study and an interventional cardiologist at the University of Iowa Hospitals & Clinics in Iowa City.

Most children who suffer in-hospital cardiac arrests are already critically ill, Girotra said. These children typically have respiratory illnesses such as pneumonia, severe infections or have had heart surgery or are receiving care for conditions such as heart failure.

At the time of their cardiac arrest, almost 85 percent of the children in the study had "non-shockable" initial heart rhythms like asystole or pulseless electrical activity. Survival rates are lower in this group than for children with "shockable" rhythms such as pulseless ventricular tachycardia or ventricular fibrillation, which are more often linked to underlying heart disease.

Over the course of the study, the proportion of children with cardiac arrest from pulseless electrical activity increased substantially, perhaps due to an increase in acute illnesses that were not heart-related, Girotra said.

"What was striking was that, despite this trend, survival still improved," Girotra said.

Survival rates also improved across age groups, gender and initial cardiac rhythm.

The researchers also explored whether better survival was due to better care during the resuscitation phase, when the heart is restarted, or better care during the post-resuscitation phase, when doctors treat underlying illness while supporting organ function. While improvements were noted in both phases, the largest gains stemmed primarily from better care during the resuscitation phase, with survival rates during that window rising from 42.9 percent in 2000 to 81.2 percent in 2009.

Although the study could not determine specifically what fueled the survival gains, Girotra said the improvement was probably due to a combination of factors, a number of which have been emphasized by the American Heart Association and other professional groups.

Those includes early recognition of cardiac arrest with the use of monitoring systems, high-quality chest compressions, timely defibrillation in patients with shockable heart rhythms, appropriate use of medicines during cardiac arrest and optimal care for resuscitated patients. The findings, he said, underscore the importance of continuing efforts to improve the quality of resuscitation.

Because of their participation in the Get With the Guidelines-Resuscitation program, hospitals in the study may differ from non-GWTG participating hospitals in important ways, Girotra said, such as additional resources and commitment to quality improvement, which may have accounted for the dramatic survival gains.

"Our results may not reflect performance at non-participating hospitals," he said.

Co-authors are John A. Spertus, M.D., M.P.H.; Yan Li, Ph.D.; Robert A. Berg, M.D.; Vinay M. Nadkarni, M.D.; and Paul S. Chan, M.D., M.Sc. Author disclosures and sources of funding are on the manuscript.

For more information:

Related Content

Patient Enrollment Completed in U.S. IDE Study of THERMOCOOL SMARTTOUCH SF Catheter
News | Clinical Study | March 15, 2018
March 15, 2018 –  Johnson & Johnson Medical Devices Companies announced today that Biosense Webster, Inc., who wo
Lexington Begins HeartSentry Clinical Trial
News | Clinical Study | February 20, 2018
February 20, 2018 – Lexington Biosciences, Inc., a development-stage medical device company, announced the commenceme
Endologix Completes Patient Enrollment in the ELEVATE IDE Clinical Study
News | Clinical Study | February 06, 2018
February 6, 2018 – Endologix, a developer and marketer of treatments for aortic disorders, announced the completion o
12-Month Results from Veryan Medical's MIMICS-2 IDE Study Presented at LINC
News | Clinical Study | February 01, 2018
February 1, 2018 – Thomas Zeller (Bad Krozingen, Germany) presented the 12-month results from Veryan Medical’s MIMICS
LimFlow Completes U.S. Feasibility Study Enrollment, Receives FDA Device Status
News | Clinical Study | February 01, 2018
February 1, 2018 –  LimFlow SA, developer of minimally-inv
ESC 2017 late breaking trial hot line study presentations.
News | Clinical Study | September 12, 2017
September 12, 2017 – The European Society of Cardiology (ESC) Congress 2017 includes several Hot Line Late-breaking C
U.K., NHS studies, weekend effect, hospital admission, atrial fibrillation, heart failure
News | Clinical Study | June 28, 2016
New research shows patients admitted to National Health Service (NHS) hospitals in the United Kingdom for atrial...
stroke risk
News | Clinical Study | August 28, 2015
Most people assume strokes only happen to octogenarians, but recent evidence suggests that survivors of childhood can
Overlay Init